Published in Radiat Oncol on February 27, 2015
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med (1992) 7.40
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol (2002) 6.74
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol (2005) 5.19
A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med (1993) 4.46
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg (2002) 1.64
Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.56
Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc (1998) 1.19
Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg (1994) 1.11
Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol (2008) 1.10
Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery (2003) 1.09
Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer (2006) 1.04
Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer. Radiat Oncol (2012) 1.04
Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Dis Esophagus (2004) 1.02
A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer (1991) 1.02
Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol (2007) 0.99
Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus (2006) 0.98
IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer. Strahlenther Onkol (2010) 0.95
Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer. Dis Esophagus (2005) 0.93
Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol (2012) 0.90
Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlenther Onkol (2010) 0.87
Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective review. J Med Imaging Radiat Oncol (2008) 0.87
Esophageal cancer: diagnosis and management. Chin J Cancer (2010) 0.84
[Treatment of patients with recurrent esophageal carcinoma]. Gan To Kagaku Ryoho (1998) 0.84
[Treatment strategy for and clinical results in patients with recurrent esophageal cancer]. Nihon Geka Gakkai Zasshi (1999) 0.82
What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer? Curr Oncol (2010) 0.81
[Patterns of initial treatment failure of esophageal cancer following radiotherapy]. Nihon Igaku Hoshasen Gakkai Zasshi (1999) 0.80